Feyza Gul Ozbay Kurt (Feyza Gül Özbay Kurt, Feyza G Ozbay Kurt)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Induced Apoptosis

Natural Killer Cells

Top Venues

Nature reviews. Clinical oncology

International journal of molecular sciences

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Samantha A Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, Nina Gutzeit, Carolina de la Torre, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma. International journal of molecular sciences 25 (12) (2024)
Samantha A Lasser, Feyza Gul Ozbay Kurt, Ihor Arkhypov, Jochen Utikal, Viktor Umansky
Myeloid-derived suppressor cells in cancer and cancer therapy. Nature reviews. Clinical oncology (2024)
Samantha A Lasser, Feyza Gul Ozbay Kurt, Ihor Arkhypov, Jochen Utikal, Viktor Umansky
Myeloid-derived suppressor cells in cancer and cancer therapy. Nature reviews. Clinical oncology 21 (2) (2024)
Samantha A Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, Nina Gutzeit, Carolina de la Torre, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma. International journal of molecular sciences 25 (12) (2024)
Feyza Gul Ozbay Kurt, Beatrice-Ana Cicortas, Bianca M Balzasch, Carolina De la Torre, Volker Ast, Ece Tavukcuoglu, Cagla Ak, Sebastian A Wohlfeil, Adelheid Cerwenka, Jochen Utikal, Viktor Umansky
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling. Journal for immunotherapy of cancer 12 (9) (2024)
Samantha A Lasser, Feyza Gul Ozbay Kurt, Ihor Arkhypov, Jochen Utikal, Viktor Umansky
Myeloid-derived suppressor cells in cancer and cancer therapy. Nature reviews. Clinical oncology 21 (2) (2024)